Top Markets
Coin of the day
ABVC BioPharma, Inc. ABVC BioPharma, Inc.

ABVC BioPharma, Inc.

ABVC
Classifica tra le azioni #28867
ABVC BioPharma, Inc. is a clinical-stage biopharmaceutical company focused on... ABVC BioPharma, Inc. is a clinical-stage biopharmaceutical company focused on creating novel drugs and medical devices to address critical, underserved healthcare requirements across the United States. The company's pipeline includes several key candidates: ABV-1501, currently undergoing Phase I/II clinical trials, is being developed as a combination treatment for triple-negative breast cancer. ABV-1504 has successfully completed Phase II clinical trials for major depressive disorders. ABV-1505 is progressing through Phase II clinical studies for attention deficit hyperactivity disorder (ADHD). ABV-1703 has concluded its Phase I clinical trials for the treatment of pancreatic cancer. ABV-1702 has also finished Phase I clinical investigations for myelodysplastic syndromes. ABV-1601 is in Phase I/II clinical trials, aimed at alleviating depression in individuals with cancer. ABV-1701 Vitargus is in development to treat conditions such as retinal detachment or vitreous hemorrhage. ABVC BioPharma maintains strategic alliances, including a co-development arrangement with Rgene Corporation, alongside collaborative agreements with BioHopeKing Corporation and BioFirst Corporation. The company's headquarters are located in Fremont, California, and it operates as a subsidiary of YuanGene Corporation.
Prezzo delle azioni
$0.9201
Capitalizzazione di mercato
$23.92M
Variazione (1 giorno)
6.23%
Variazione (1 anno)
-67.72%
Paese
US
Scambia ABVC BioPharma, Inc. (ABVC)

Categoria

Storico del prezzo dell'azione per ABVC BioPharma, Inc. (ABVC)
Prezzo di chiusura più alto: $0.94 il 2026-08-01

Prezzo di chiusura più basso: $455.54K il 2004-11-01
Storico del prezzo dell'azione di ABVC BioPharma, Inc. dal 2004 al 2026
Andamento annuale del prezzo dell'azione
Anno Performance
2026 (TTM) -15.73%
2025 331.39%
2024 -56.69%
2023 -82.53%
2022 -79.50%
2021 -27.15%
2020 -18.60%
2019 -79.88%
2018 -21.05%
2017 0.00%
2016 -74.88%
2015 -42.11%
2014 -17.94%
2013 -48.16%
2012 -81.81%
2011 -12.18%
2010 -91.16%
2009 -58.61%
2008 -66.11%
2007 -5.25%
2006 160.11%
2005 191.95%
2004 0.00%
Prezzo dell'azione per aziende simili o concorrenti
Azienda Prezzo dell'azione Variazione 1a% Il paese
$542.79 38.90%
US
$1.02K 55.75%
NL
$142.08 409.08%
US
$117.42 -19.34%
AU
$753.28 8.59%
CH